These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Effectiveness, safety, and costs of measures for prevention of gastropathy due to the use of nonsteroidal antiinflammatory drugs]. Salentijn GJ Ned Tijdschr Geneeskd; 1999 Nov; 143(46):2340. PubMed ID: 10589227 [No Abstract] [Full Text] [Related]
4. [NSAID-induced damage to the gastrointestinal mucosa]. Rodonezhskaia EV; Kharchenko NV Lik Sprava; 2001; (4):179-80. PubMed ID: 11692710 [TBL] [Abstract][Full Text] [Related]
5. Helicobacter pylori: a risk and severity factor of non-steroidal anti-inflammatory drug induced gastropathy. Heresbach D; Raoul JL; Bretagne JF; Minet J; Donnio PY; Ramée MP; Siproudhis L; Gosselin M Gut; 1992 Dec; 33(12):1608-11. PubMed ID: 1487160 [TBL] [Abstract][Full Text] [Related]
6. Non-steroidal anti-inflammatory drugs request parity with Helicobacter pylori. Ladwa M; Takeuchi K; Bjarnason I Scand J Gastroenterol; 2006 Apr; 41(4):373-5. PubMed ID: 16635902 [No Abstract] [Full Text] [Related]
7. Helicobacter pylori and NSAIDS--more questions than answers. Ryan MJ Am J Gastroenterol; 1991 Aug; 86(8):1090-1. PubMed ID: 1858749 [No Abstract] [Full Text] [Related]
8. [Gastropathy caused by nonsteriod anti-inflammatory drugs: from understanding of development mechanisms to planning strategy of treatment and prophylaxis]. Akhmedov VA; Vinzhegina VA; Sudakova AN; Rozenblit EI Ter Arkh; 2007; 79(2):81-5. PubMed ID: 17460975 [No Abstract] [Full Text] [Related]
9. [Helicobacter pylori and non-steroidal anti-inflammatory agents]. Knoflach P Acta Med Austriaca; 2000; 27(4):126-8. PubMed ID: 10989682 [TBL] [Abstract][Full Text] [Related]
10. [Acid-related diseases. Should H. pylori be eradicated in patients who will receive prolonged NSAID treatment?]. Lanas Arbeloa A Gastroenterol Hepatol; 2009 Mar; 32(3):173-4. PubMed ID: 19268192 [No Abstract] [Full Text] [Related]
11. [Helicobacter pylori infection and diseases of the stomach and duodenum]. Svestka T; Krechler T; Brůha R; Jablonská M Cas Lek Cesk; 2004; 143(11):734-7. PubMed ID: 15628566 [TBL] [Abstract][Full Text] [Related]
12. Are patients at increased risk? Sloan J Can Fam Physician; 1998 Oct; 44():2065-6. PubMed ID: 9805153 [No Abstract] [Full Text] [Related]
13. Definitions and classification of dyspepsia: pH, Helicobacter pylori, non-steroidal anti-inflammatory drugs--should we include gastro-oesophageal reflux disease? Bazzoli F Aliment Pharmacol Ther; 2005 Mar; 21 Suppl 1():15-6, 21-4. PubMed ID: 15755270 [No Abstract] [Full Text] [Related]
14. Helicobacter pylori and portal hypertensive gastropathy. Guslandi M Am J Gastroenterol; 1997 Apr; 92(4):723. PubMed ID: 9128347 [No Abstract] [Full Text] [Related]
15. Loss of non-steroidal anti-inflammatory drug hypersensitivity after Helicobacter pylori eradication. Neynaber S; Berking C; Przybilla B J Eur Acad Dermatol Venereol; 2009 Feb; 23(2):196-7. PubMed ID: 18507698 [No Abstract] [Full Text] [Related]